DJIA 17,719.92 -78.57 -0.44%
NASDAQ 5,108.67 -18.86 -0.37%
S&P 500 2,080.41 -9.70 -0.46%
market minute promo


31.91 -0.84 (-2.56%)

Quote as of

Extended Hours: $31.90 -$0.01 (-0.02%)
Quote as of (NASDAQ)

company name or ticker

Recent Quotes

CEMP $31.91 -2.56%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $33.21
Previous Close $32.75
Daily Range $31.23 - $33.32
52-Week Range $13.45 - $46.99
Market Cap $1.4B
P/E Ratio -21.27
Dividend (Yield) $0.00 (0.0%)
Volume 864,109
Average Daily Volume 2,551,055
Current FY EPS -$2.06



CEMPRA INC (CEMP) Description

Cempra Inc is a clinical-stage pharmaceutical company which is developing antibiotics to meet critical unmet medical needs in the treatment of bacterial infectious diseases particularly respiratory tract infections and skin and skin structure infections. Website:

News & Commentary

Why Cempra Inc is Up Big Today

An updated investor presentation appears to have bulls excited, and shares are soaring today as a result.

Solithromycin From Cempra Is Positioning To Be The Treatment Of Choice For CABP

Cempra (CEMP) Is Today's Perilous Reversal Stock

Morgan Stanley Upgrades Cempra To Overweight

Cempra (CEMP) Is Today's Dead Cat Bounce Stock

Cempra’s New Drug Holds Potential, but Risk for Investors

Cempra Rallies Over $4 Off Friday's Low ($15.43)

Cempra (CEMP) In A Perilous Reversal

5 High-Risk, High-Reward Stocks We're Watching

Our Motley Fool contributors have these high-risk names on their radar, and perhaps you should, too.

Cempra (CEMP) CEO Dr. Prabha Fernandes on Q3 2015 Results - Earnings Call Transcript

See More CEMP News...